Gainers
- Blue Water Vaccines, Inc. (NASDAQ:BWV) shares rose 38.3% to $1.62 in pre-market trading. Blue Water Vaccines recently appointed Frank Jaeger, seasoned commercial operations and business development executive, as Senior Vice President of Marketing and Business Development.
- MDxHealth SA (NASDAQ:MDXH) rose 23.3% to $4.44 in pre-market trading after the company said UnitedHealthcare will provide commercial coverage for the Genomic Prostate Score (GPS) test.
- Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) shares rose 22.8% to $4.46 in pre-market trading as the company announced plans to acquire Phase 2 program for 225Ac-PSMA I&T, a radiopharmaceutical targeting metastatic castrate resistant prostate cancer..
- Palantir Technologies Inc. (NYSE:PLTR) rose 17% to $8.90 in pre-market trading after the company reported better-than-expected fourth-quarter financial results. The company also issued first-quarter and FY23 guidance.
- GeoVax Labs, Inc. (NASDAQ:GOVX) rose 15.3% to $0.8999 in pre-market trading.
- China Pharma Holdings, Inc. (NYSE:CPHI) rose 13.1% to $0.1096 in pre-market trading after dropping 7% on Monday. China Pharma, during December, announced the launch of N95 medical protective mask.
- Soligenix, Inc. (NASDAQ:SNGX) shares rose 11.5% to $6.51 in pre-market trading. Soligenix recently announced a reverse stock split.
- ContextLogic Inc. (NASDAQ:WISH) rose 9.8% to $0.9650 in pre-market trading. ContextLogic shares jumped over 37% on Monday after Citron Research made bullish comments on the stock on Twitter.
- TMC the metals company Inc. (NASDAQ:TMC) rose 8.6% to $1.13 in pre-market trading after dropping around 5% on Monday. The company, during December, filed prospectus for offering of up to $30 million common shares.
- ContraFect Corporation (NASDAQ:CFRX) rose 8.4% to $0.0698 in pre-market trading after declining around 4% on Monday.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Losers
- T2 Biosystems, Inc. (NASDAQ:TTOO) shares fell 16.4% to $1.17 in pre-market trading after the company reported a proposed public offering and announced results upon completion of the U.S. clinical evaluation for the T2Biothreat Panel.
- Cerberus Cyber Sentinel Corporation (NASDAQ:CISO) shares dropped 13.5% to $0.95 in pre-market trading after the company reported a proposed public offering of common stock.
- Outset Medical, Inc. (NASDAQ:OM) fell 11.8% to $25.06 in pre-market trading after the company reported Q4 results and issued FY23 guidance.
- Guardforce AI Co., Limited (NASDAQ:GFAI) fell 11.8% to $13.67 in pre-market after dropping 18% on Monday. Guardforce AI recently announced a 1-for-40 reverse split.
- Vallon Pharmaceuticals, Inc. (NASDAQ:VLON) fell 7.9% to $0.8105 in pre-market trading after surging 90% on Monday.
- Edible Garden AG Incorporated (NASDAQ:EDBL) fell 7% to $3.83 in pre-market trading after dropping around 8% on Monday. Edible Garden recently announced pricing of an upsized $10.2 million underwritten public offering.
- Sharps Technology, Inc. (NASDAQ:STSS) fell 6.5% to $1.30 in pre-market trading. Sharps Technology recently announced a $3.8 million private placement at $1.69 per share.
- Imperial Petroleum Inc. (NASDAQ:IMPP) shares fell 6.4% to $0.3345 in pre-market trading after jumping over 36% on Monday. The company is scheduled to release its fourth quarter financial results before the market opens on Feb. 15, 2023.
- SHF Holdings, Inc (NASDAQ:SHFS) fell 6.1% to $0.8003 in pre-market trading after gaining 12% on Monday.
- Atreca, Inc. (NASDAQ:BCEL) fell 5.8% to $1.62 in pre-market trading after surging around 14% on Monday. Atreca and Xencor announced plans to develop T Cell engaging bispecific antibody directed against novel solid tumor target.
Now Read This: Coca-Cola, Marriott International And 3 Stocks To Watch Heading Into Tuesday
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.